ATE494386T1 - Materialien und verfahren zur erhöhung der peptidkettenexpression - Google Patents

Materialien und verfahren zur erhöhung der peptidkettenexpression

Info

Publication number
ATE494386T1
ATE494386T1 AT06789720T AT06789720T ATE494386T1 AT E494386 T1 ATE494386 T1 AT E494386T1 AT 06789720 T AT06789720 T AT 06789720T AT 06789720 T AT06789720 T AT 06789720T AT E494386 T1 ATE494386 T1 AT E494386T1
Authority
AT
Austria
Prior art keywords
peptide chain
chain expression
methods
materials
increase peptide
Prior art date
Application number
AT06789720T
Other languages
English (en)
Inventor
Pamela Nelson
Gordon Moore
Barry Morse
Haimanti Dorai
Bernard Scallon
Linda Hendricks
Original Assignee
Centocor Ortho Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc
Application granted granted Critical
Publication of ATE494386T1 publication Critical patent/ATE494386T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/248—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT06789720T 2005-08-11 2006-08-11 Materialien und verfahren zur erhöhung der peptidkettenexpression ATE494386T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70756405P 2005-08-11 2005-08-11
PCT/US2006/031506 WO2007022009A2 (en) 2005-08-11 2006-08-11 Materials and methods to increase peptide chain expression

Publications (1)

Publication Number Publication Date
ATE494386T1 true ATE494386T1 (de) 2011-01-15

Family

ID=37758241

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06789720T ATE494386T1 (de) 2005-08-11 2006-08-11 Materialien und verfahren zur erhöhung der peptidkettenexpression

Country Status (6)

Country Link
US (1) US7498150B2 (de)
EP (1) EP1957660B1 (de)
JP (1) JP4958905B2 (de)
AT (1) ATE494386T1 (de)
DE (1) DE602006019486D1 (de)
WO (1) WO2007022009A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010001991A (es) 2007-08-20 2010-05-27 Myfc Ab Montaje de celda de combustible que tiene sensor de retroalimentacion.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60233049D1 (de) 2001-01-26 2009-09-03 Selexis Sa Matrix-anheftungsregionen und verfahren zu deren verwendung

Also Published As

Publication number Publication date
EP1957660A4 (de) 2009-06-17
DE602006019486D1 (de) 2011-02-17
WO2007022009A3 (en) 2007-11-22
US7498150B2 (en) 2009-03-03
WO2007022009A2 (en) 2007-02-22
JP4958905B2 (ja) 2012-06-20
EP1957660A2 (de) 2008-08-20
JP2009504160A (ja) 2009-02-05
EP1957660B1 (de) 2011-01-05
US20080213829A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
CY1112924T1 (el) Κυτταροδιαπερατοι αναστολεις της jnk-σηματοδοτικης πορειας μεταγωγης
CO6341638A2 (es) Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas y metodos para su uso
DK2617814T3 (da) Phytaser, nukleinsyrer, der koder for disse, og fremgangsmåder til frembringelse og anvendelse heraf
ATE517995T1 (de) Prozess zur chromosomalen integration und zum ersatz von dna-sequenzen in clostridia
MX2011007467A (es) Dominios modulares de union a dna y metodos de uso.
PL393466A1 (pl) Sposób stymulacji biogenicznego wytwarzania metanu z formacji węglowodoronośnych
MX2010008099A (es) Anticuerpos y angiopoyetina-2 estabilizados y sus usos.
EA200901110A1 (ru) Рекомбинантная клетка-хозяин для получения соединения, представляющего интерес
IL216796A (en) Isolated nucleic acid molecule encoding an alternative light chain protein (slc) and a method for the expression of slc protein
ATE449193T1 (de) Verfahren zur bestimmung der kopienummer
IN2012DN03825A (de)
EP1941050A4 (de) Verfahren und zusammensetzung zur erzeugung von einzelsequenz-dna-sonden, markierung von dna-sonden und verwendung dieser sonden
GB201020995D0 (en) Biological materials and uses thereof
BR112013007862A2 (pt) ácidos nucleicos manipulados e métodos de uso dos mesmos.
CY1109892T1 (el) Φυτα ανθεκτικα στην πιεση
DE602007012858D1 (de) Verfahren zur durchführung homologer rekombinationen in pflanzen
ATE490954T1 (de) Estergebundene geminitensidverbindungen zur verwendung in der gentherapie
MX2010001490A (es) Acidos nucleicos de enlace sdf-1 y uso de los mismos.
DE602006010400D1 (de) Olanzapin-analoga und verfahren zu ihrer verwendung
NO20076126L (no) Mutasjoner i OAS1-gener
ATE512215T1 (de) Verfahren und mittel zur anreicherung, entfernung und zum nachweis von listerien
WO2009137145A3 (en) Transcriptional control in alicyclobacillus acidocaldarius and associated genes, proteins, and methods
NZ583783A (en) Avian interferon-lambda polypeptide and genetic sequences encoding the same
NZ604019A (en) Methyltransferase nucleic acids and polypeptides
MX2011000281A (es) Fibrinogeno recombinante.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties